SPY383.63+6.93 1.84%
DIA315.24+5.66 1.83%
IXIC12,920.15+196.68 1.55%

BRIEF-Ocumension Therapeutics Says Phase III Clinical Trial OT-702 (LY09004) Has Been Initiated

· 02/08/2021 00:02
BRIEF-Ocumension Therapeutics Says Phase III Clinical Trial OT-702 (LY09004) Has Been Initiated

- Ocumension Therapeutics 1477.HK:

  • PHASE III CLINICAL TRIAL OF RECENTLY IN-LICENSED DRUG CANDIDATE OF GROUP, OT-702 (LY09004) INITIATED

Source text for Eikon: ID:nHKS4W5Jyp

Further company coverage: 1477.HK


((Reuters.Briefs@thomsonreuters.com;))